BIOTURM LIMITED

Company Registration Number:
10646999 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

BIOTURM LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

BIOTURM LIMITED

Company Information

for the Period Ended 31 March 2024




Director: MR SUPHIL PHILIPOSE
Registered office: 1
Coneywell Court
Northampton
England
NN3 9DP
Company Registration Number: 10646999 (England and Wales)

BIOTURM LIMITED

Directors' Report Period Ended 31 March 2024

The directors present their report with the financial statements of the company for the period ended 31 March 2024

Principal Activities

The principal activity of the company during the year under review was that of wholesale of pharmaceutical goods.

Directors

The director(s) shown below were appointed to the company during the period
MR SUPHIL PHILIPOSE
01 April 2023

This report was approved by the board of directors on 29 August 2025
And Signed On Behalf Of The Board By:

Name: MR SUPHIL PHILIPOSE
Status: Director

BIOTURM LIMITED

Balance sheet

As at 31 March 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 208 277
Total fixed assets: 208 277
Current assets
Stocks: 0 3,790
Debtors: 14,556 17,986
Cash at bank and in hand: 0 2,418
Total current assets: 14,556 24,194
Creditors: amounts falling due within one year: ( 93,429 ) ( 103,042 )
Net current assets (liabilities): ( 78,873 ) ( 78,848 )
Total assets less current liabilities: ( 78,665 ) ( 78,571 )
Creditors: amounts falling due after more than one year: ( 11,207 ) ( 11,207 )
Total net assets (liabilities): ( 89,872 ) ( 89,778 )

The notes form part of these financial statements

BIOTURM LIMITED

Balance sheet continued

As at 31 March 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: ( 90,872 ) ( 90,778 )
Shareholders funds: ( 89,872 ) ( 89,778 )

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 29 August 2025
And Signed On Behalf Of The Board By:

Name: MR SUPHIL PHILIPOSE
Status: Director

The notes form part of these financial statements

BIOTURM LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Tangible fixed assets depreciation policy

    Fiitting, Furniture & Equipment is depreciation under reducing Balance method @ 25%

BIOTURM LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

BIOTURM LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

BIOTURM LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible Assets

Total
Cost £
At 01 April 2023 780
Additions -
Disposals -
Revaluations -
Transfers -
At 31 March 2024 780
Depreciation
At 01 April 2023 503
Charge for year 69
On disposals -
Other adjustments -
At 31 March 2024 572
Net book value
At 31 March 2024 208
At 31 March 2023 277